Original price was: $999.00.$899.00Current price is: $899.00.
Verzenio is indicated for the treatment of hormone receptor-positive (HR+) and human epidermal growth factor receptor type 2 receptor-negative (HER2-) advanced or metastatic breast cancer:
– in combination with first-line endocrine therapy with an aromatase inhibitor;
– in combination with fulvestrant, prescribed as first or second line of endocrine therapy;
– as monotherapy in patients with disease progression after endocrine therapy and one or two lines of previous chemotherapy for the metastatic stage of the disease.
Active ingredient: abemaciclib
Prescription medicine.
| Дозировка | 50 Mg, 100 Mg, 150 Mg |
|---|
